Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal mesotheliomia [corrected].

Authors :: Sugarbaker PH
Source :: Annals of surgical oncology [Ann Surg Oncol] 2010 Jun; Vol. 17 (6), pp. 1710-2; author reply 1713-4.
Publication Year :: 2010

Subjects :: Humans
Mesothelioma mortality
Mesothelioma pathology
Mesothelioma therapy
Peritoneal Neoplasms mortality
Peritoneal Neoplasms pathology
Peritoneal Neoplasms therapy
Survival Analysis
Treatment Outcome
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Hyperthermia, Induced
Injections, Intraperitoneal methods
Mesothelioma drug therapy
Mesothelioma surgery
Peritoneal Neoplasms drug therapy
Peritoneal Neoplasms surgery

Full Text Access

Tools